MBX Biosciences, Inc. Common Stock

MBX | NASDAQ | 0 Urmăritori

$11.37

-4.13%

-$0.49

Urmărește

Overview Metrics Financials

Company Quality

Profitability Score

9/100

Solvency Score

75/100

Dividends

Dividends data currently unavailable.

Earnings

6/16/2025

in 7 days

Revenue est.

-0.81

EPS est.

My Notes

You haven't added any notes for this stock yet. Use this space to record your insights or strategies.

Profile

Healthcare

Sector

Biotechnology

Industrie

Mr. Peter Kent Hawryluk MBA

CEO

Angajați

Carmel

Sediu

Țară

Key Metrics TTM

Valuation

Market cap.

$380M

Enterprise Value

$350M

Price to Earnings

-5.17

Price to Sales

0.00

Price to Book

1.61

Price to Cash Flow

-5.65

Profitability

Return on Assets

-29.87%

Return on Equity

-44.10%

Return on Invested Capital

-34.56%

Gross Margin

0.00%

Operating Margin

0.00%

Net Margin

0.00%

Liquidity

Quick Ratio

23.31

Current Ratio

23.31

Cash Ratio

2.85

Inventory Turnover

0.00

Asset Turnover

0.00

Total Liabilities

$11M

Solvency

Debt to Assets

0.0005

Debt to Equity

N/A

Interest Coverage

0.00

Equity Ratio

0.96

Long-term Debt to Cap.

0.00

Altman Z-Score

23.31

Performance

Performance data currently unavailable.

Earnings Waterfall

Debt level and coverage

Debt level and coverage data currently unavailable.

Earnings

Feed

There are no posts to show right now.